Providing expert due diligence for the reformulation of a marketed biologic
Challenge
An established European pharma company needed an opportunity assessment for a reformulation of a marketed biologic.
Solution
We quantified the market opportunity and assessed the market positioning and unique selling propositions (USPs) of the target product. We also reviewed the competitive environment, assessing sales and pricing of competitor products (based on IMS data) and likely competitive responses from established players in the market.
Related Case Studies
Explore similar engagements and see how we've helped other clients achieve their goals.
Strategy & Commercialization
Evaluating the Commercial Viability of a Novel Neonatal Therapy Approach
Challenge: A leading U.S. children’s hospital commissioned an independent review of a novel therapeutic approach for rare neonatal diseases. The principal investigator (PI) - a...
Strategy & Commercialization
Landscape Assessment of Novel Pain Targets for R&D Prioritization
Challenge: A privately held US-based biotech company specializing in pain therapeutics had developed a cutting-edge drug discovery platform utilizing multi-omic, tissue-specific...
Strategy & Commercialization
Axl/merTK target assessment for an AI-driven drug discovery company
Challenge: An AI-driven drug discovery company requested an expert third party assessment of the attractiveness and risks of a particular discovery strategy focused on a dual...
Strategy & Commercialization
Technical Feasibility Ranking of Gene Therapies for CNS Diseases
Challenge: A mid-sized pharmaceutical company was considering the option of expanding into developing gene therapies for CNS diseases. Alacrita was asked to help them evaluate and...
Interested in Learning More?
Contact us to discuss how we can support your project with similar expertise.